Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Patusky currently holds 2,910 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Patusky has been a net seller of UTHR stock. They have purchased $2.4K and sold $21.9M worth of shares.
Christopher Patusky's most recent insider trade was on Apr 17, 2026, when they sold 1,000 shares at $0.00 per share.
Christopher Patusky serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 213 insider transactions totaling $21.9M over their tenure at the company.
Christopher Patusky holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Christopher Patusky has shown a selling trading pattern, with $2.4K in total purchases and $21.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Patusky was on Sep 4, 2024, when they sold $1.5M worth of UTHR shares. This transaction involved 4,300 shares at $353.36 per share.
Christopher Patusky currently owns 2,910 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Patusky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Patusky has 213 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for Christopher Patusky and 40,000+ other insiders.